Table of Contents:
  • Changing treatment paradigm for stage IV non-small cell lung cancer
  • Immunotherapy after chemoradiation in unresectable stage III lung cancer
  • Investigating immune checkpoint inhibition in early-stage surgically-resectable lung cancer
  • Immunotherapy for small cell lung cancer
  • Biomarkers of response to immunotherapy in lung cancer